CCO Medical Specialties Podcast

Clinical Care Options
  • 4,9 (10)
  • CURSOS
  • BIMESTRAL

Weekly updates on new data, current advances, and best practices in patient care for a variety of medical specialties including NASH, diabetes, muscular dystrophy, and more from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.

  1. Conversations in Chronic Cough: A Pulmonologist’s Perspective

    9 DE SET.

    Conversations in Chronic Cough: A Pulmonologist’s Perspective

    Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies. Presenter Peter Dicpinigaitis, MD Professor of Medicine Albert Einstein College of Medicine Division of Critical Care Medicine Montefiore Medical Center Director, Montefiore Cough Center Bronx, New York Link to full program: https://bit.ly/4kweynG

    17min

  2. 11 DE JUL.

    Conversations in Chronic Cough: An Otolaryngologist’s Perspective

    Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case. Presenter Michael S. Benninger, MD Professor of Otolaryngology-Head and Neck Surgery Lerner College of Medicine The Cleveland Clinic President, International Association of Phonosurgery Cleveland, Ohio Link to full program: https://bit.ly/4kweynG

    18min
  3. Quality Improvement in Obesity Care: How to Integrate Comprehensive Diabetes Management

    10 DE JUL.

    Quality Improvement in Obesity Care: How to Integrate Comprehensive Diabetes Management

    Listen in as Joseph Kim, MD, MPH, MBA, and Colten Bracken, MD, FAAFP, discuss how to integrate comprehensive diabetes management to improve the quality of their obesity care delivery, including:  Documenting obesity as a diagnosis for patients with diabetes when appropriateStreamlining processes to ensure patients return for follow-upDedicating a care manager to initiate patient outreachImplementing pharmacotherapy strategies to help patients control their A1C and achieve weight loss simultaneously.Presenters Joseph Kim, MD, MPH, MBA President Q Synthesis, LLC Newtown, Pennsylvania Colten Bracken, MD, FAAFP Board of Directors for RHAU & UAFP Owner/Medical Director Main Street Family Medicine, PLLC Enterprise, Utah Link to full program:  https://bit.ly/3IBFZi5

    19min
  4. Key PBC Studies From EASL and DDW 2025

    7 DE JUL.

    Key PBC Studies From EASL and DDW 2025

    In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH​, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include: Steatotic liver disease and PBCVibration-controlled transient elastography (VCTE) and discordant biochemical responses in PBCPPAR agonists and IBATs for PBC treatment  Presenter: Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH Associate Professor NIHR Birmingham BRC University of Birmingham Consultant Hepatologist, Liver Unit University Hospitals Birmingham Birmingham, United Kingdom   Link to full program:  https://bit.ly/44ySoL3 Follow along with the slides:  https://bit.ly/3IvwQrj Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify .

    19min
  5. Evidence-Based Care in Atopic Dermatitis: Practical Considerations for IL-13 Inhibitors for Moderate to Severe Disease

    25 DE JUN.

    Evidence-Based Care in Atopic Dermatitis: Practical Considerations for IL-13 Inhibitors for Moderate to Severe Disease

    In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including: Patient candidacy considerationsTreatment advancement strategies that go beyond topical therapiesThe importance of patient-centered care that address patients’ fears and needsA detailed patient case to highlight take home pointsPresenter Daniel C. Butler, MD​ Assistant Dean Student Affairs​ University of Arizona College of Medicine – Tucson​ Tucson, Arizona Shawn G. Kwatra, MD​ Dr. Joseph W. Burnett Endowed Professor and Chair ​ Department of Dermatology​ University of Maryland School of Medicine​ Baltimore, Maryland Program page: https://bit.ly/4kTP04D

    10min
  6. Evidence-Based Care in Atopic Dermatitis: IL-13 Inhibitors to Treat Moderate to Severe Disease

    25 DE JUN.

    Evidence-Based Care in Atopic Dermatitis: IL-13 Inhibitors to Treat Moderate to Severe Disease

    In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including: The available biologic therapies that specifically target IL-13Where these agents fall in the 2024 American Academy of Dermatology treatment algorithmHow these agents compare to other AD therapies like topical corticosteroids and oral JAK inhibitorsA detailed patient case to highlight take home pointsPresenter Andrew F. Alexis, MD, MPH​ Professor of Clinical Dermatology​ Weill Cornell Medical College ​ New York, New York Daniel C. Butler, MD​ Assistant Dean Student Affairs​ University of Arizona College of Medicine – Tucson​ Tucson, Arizona Shawn G. Kwatra, MD​ Dr. Joseph W. Burnett Endowed Professor and Chair ​ Department of Dermatology​ University of Maryland School of Medicine​ Baltimore, Maryland Program page: https://bit.ly/4kTP04D

    16min
  7. Quality Improvement in Obesity Care: How to Manage Prior Authorizations for Antiobesity Medications

    24 DE JUN.

    Quality Improvement in Obesity Care: How to Manage Prior Authorizations for Antiobesity Medications

    Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including: The information to collect during patient visitsThe available resources to help you submit prior authorizationsThe supporting documents that are often necessary to accompany prior authorizationsHow to address denials and appealsWhen to access manufacturer-based or foundation-based financial assistancePresenters Joseph Kim, MD, MPH, MBA President Q Synthesis, LLC Newtown, Pennsylvania Manish Shah, MD Clinical Associate Faculty MS1 Preceptor University of Florida College of Medicine Gainesville, Florida Martha Grugel, MA Medical Assistant Wesley Chapel, Florida Link to full program:  https://bit.ly/45P0v8z

    27min
  8. Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

    24 DE JUN.

    Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

    In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including: Contributors to epidermal barrier dysfunction (eg, environmental triggers)IL-13 as a key cytokine in AD pathogenesisTargeted AD therapies that inhibit IL-13A detailed patient case to highlight take-home pointsPresenter Andrew F. Alexis, MD, MPH​ Professor of Clinical Dermatology​ Weill Cornell Medical College ​ New York, New York Daniel C. Butler, MD​ Assistant Dean Student Affairs​ University of Arizona College of Medicine – Tucson​ Tucson, Arizona Program page:  https://bit.ly/4kTP04D

    12min
Ver tudo (59)

Classificações e avaliações

4,9
de 5
10 avaliações

Sobre

Weekly updates on new data, current advances, and best practices in patient care for a variety of medical specialties including NASH, diabetes, muscular dystrophy, and more from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.

Informações

  • Criado por
    Clinical Care Options
  • Anos de atividade
    2020 - 2025
  • Episódios
    59
  • Classificação
    Livre
  • Copyright
    © 2019-2020 CCO Podcast: Medical Specialties
  • Site do podcast
    CCO Medical Specialties Podcast